ID24613A - Zat-zat pelepas secara terus-menerus untuk obat-obat dan komposisi-komposisi obat yang secara terus-menerus dilepas yang mengandung yang sama - Google Patents

Zat-zat pelepas secara terus-menerus untuk obat-obat dan komposisi-komposisi obat yang secara terus-menerus dilepas yang mengandung yang sama

Info

Publication number
ID24613A
ID24613A IDW20001096A ID20001096A ID24613A ID 24613 A ID24613 A ID 24613A ID W20001096 A IDW20001096 A ID W20001096A ID 20001096 A ID20001096 A ID 20001096A ID 24613 A ID24613 A ID 24613A
Authority
ID
Indonesia
Prior art keywords
pleasures
medicines
drugs
continuous
composition
Prior art date
Application number
IDW20001096A
Other languages
English (en)
Indonesian (id)
Inventor
Takeshi Goto
Hiroshi Sorimachi
Kazuhisa Yoshitake
Toshio Itoyama
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of ID24613A publication Critical patent/ID24613A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IDW20001096A 1997-11-10 1998-10-30 Zat-zat pelepas secara terus-menerus untuk obat-obat dan komposisi-komposisi obat yang secara terus-menerus dilepas yang mengandung yang sama ID24613A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30737197 1997-11-10

Publications (1)

Publication Number Publication Date
ID24613A true ID24613A (id) 2000-07-27

Family

ID=17968268

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001096A ID24613A (id) 1997-11-10 1998-10-30 Zat-zat pelepas secara terus-menerus untuk obat-obat dan komposisi-komposisi obat yang secara terus-menerus dilepas yang mengandung yang sama

Country Status (9)

Country Link
US (1) US6277366B1 (fr)
EP (1) EP1051977A1 (fr)
KR (1) KR20010031911A (fr)
CN (1) CN1278738A (fr)
AU (1) AU733802B2 (fr)
CA (1) CA2309597A1 (fr)
ID (1) ID24613A (fr)
RU (1) RU2209087C2 (fr)
WO (1) WO1999024072A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005280058B2 (en) 2004-08-25 2010-09-02 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof
US7799777B2 (en) 2006-01-05 2010-09-21 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US20100155357A1 (en) * 2006-06-12 2010-06-24 The Clorox Company Liner Material
AU2008272923A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US10668157B2 (en) 2014-04-17 2020-06-02 Seed Co., Ltd. Anionic drug-containing medical device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
US3138525A (en) 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
GB1218102A (en) 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
IT1110989B (it) 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
US4460577A (en) 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
IL90245A (en) 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
JPH0352824A (ja) 1989-07-14 1991-03-07 Cortial:Soc 樹脂‐活性成分複合体を主薬とする新規な徐放性薬剤形態
US5840339A (en) * 1991-07-30 1998-11-24 Kunin; Robert Blood cholesterol reducing pharmaceutical composition
EP0622078B1 (fr) * 1992-01-14 1999-09-01 Hisamitsu Pharmaceutical Co., Inc. Reducteur du taux de cholesterol
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JP2737052B2 (ja) 1995-11-13 1998-04-08 久光製薬株式会社 非架橋型陰イオン交換樹脂

Also Published As

Publication number Publication date
AU733802B2 (en) 2001-05-24
RU2209087C2 (ru) 2003-07-27
EP1051977A1 (fr) 2000-11-15
US6277366B1 (en) 2001-08-21
CN1278738A (zh) 2001-01-03
KR20010031911A (ko) 2001-04-16
AU2704299A (en) 1999-05-31
CA2309597A1 (fr) 1999-05-20
WO1999024072A1 (fr) 1999-05-20

Similar Documents

Publication Publication Date Title
ZA987800B (en) Pharmaceutical composition of meloxicam
ID17128A (id) Granulat untuk pembuatan komposisi-komposisi cepat mengurai dan cepat larut yang mengandung jumlah obat yang tinggi
ID21806A (id) Bentuk penakaran farmasi yang secara cepat dilepaskan dan yang menutup rasa
FI980822A0 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ID18663A (id) Komposisi farmasi berlapis enterik
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
PT907364E (pt) Composicao farmaceutica de libertacao sustida
NO995500D0 (no) Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
ID20604A (id) Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya
NO981166L (no) Fremstilling av askorbylmonofosfater
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
ID24700A (id) Partikel hidroksiapatit berpori sebagai pembawa bahan obat
ID17076A (id) Turunan 2,4-disubstitusi pirimidin, proses untuk pembuatan zat yang sama dan komposisi farmasi yang mengandung zat yang sama
HUP0002346A3 (en) Pharmaceutical composition for the treatment of mental illness in mammals
FI964619A (fi) Epilepsialääkkeiden iholle annostelu
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
ID24613A (id) Zat-zat pelepas secara terus-menerus untuk obat-obat dan komposisi-komposisi obat yang secara terus-menerus dilepas yang mengandung yang sama
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ID19931A (id) Senyawa cincin 7-anggota terfusi tersubstitusi sulfonamida, penggunaannya sebagai obat-obatan, dan pembuatan sediaan farmasi yang mengandung senyawa tersebut